182 related articles for article (PubMed ID: 1802616)
1. Molecular genetics of pyrogenic exotoxin "superantigens" of group A streptococci and Staphylococcus aureus.
Lee PK; Schlievert PM
Curr Top Microbiol Immunol; 1991; 174():1-19. PubMed ID: 1802616
[No Abstract] [Full Text] [Related]
2. Neutralization of streptococcal pyrogenic exotoxins and staphylococcal enterotoxins by antiserum to synthetic peptides representing conserved amino acid motifs.
Bannan JD; Mingo FR; Viteri AL; Zabriskie JB
Adv Exp Med Biol; 1997; 418():903-7. PubMed ID: 9331795
[No Abstract] [Full Text] [Related]
3. Streptococcal pyrogenic exotoxin type A (scarlet fever toxin) is related to Staphylococcus aureus enterotoxin B.
Johnson LP; L'Italien JJ; Schlievert PM
Mol Gen Genet; 1986 May; 203(2):354-6. PubMed ID: 3526093
[TBL] [Abstract][Full Text] [Related]
4. Structure and function of streptococcal and staphylococcal superantigens in septic shock.
Bannan J; Visvanathan K; Zabriskie JB
Infect Dis Clin North Am; 1999 Jun; 13(2):387-96, ix. PubMed ID: 10340173
[TBL] [Abstract][Full Text] [Related]
5. Superantigens and pseudosuperantigens of gram-positive cocci.
Fleischer B; Gerlach D; Fuhrmann A; Schmidt KH
Med Microbiol Immunol; 1995 May; 184(1):1-8. PubMed ID: 8538573
[TBL] [Abstract][Full Text] [Related]
6. Structural evidence for the evolution of pyrogenic toxin superantigens.
Mitchell DT; Levitt DG; Schlievert PM; Ohlendorf DH
J Mol Evol; 2000 Dec; 51(6):520-31. PubMed ID: 11116326
[TBL] [Abstract][Full Text] [Related]
7. Staphylococcal enterotoxins, toxic shock syndrome toxin and streptococcal pyrogenic exotoxins: a comparative study of their molecular biology.
Betley MJ; Borst DW; Regassa LB
Chem Immunol; 1992; 55():1-35. PubMed ID: 1418613
[No Abstract] [Full Text] [Related]
8. Sensitive enzyme-linked immunosorbent assays for the detection of bacterial superantigens and antibodies against them in human plasma.
Miwa K; Fukuyama M; Sakai R; Shimizu S; Ida N; Endo M; Igarashi H
Microbiol Immunol; 2000; 44(6):519-23. PubMed ID: 10941935
[TBL] [Abstract][Full Text] [Related]
9. Immunologic cross-reactivity of type A streptococcal exotoxin (erythrogenic toxin) and staphylococcal enterotoxins B and C1.
Hynes WL; Weeks CR; Iandolo JJ; Ferretti JJ
Infect Immun; 1987 Mar; 55(3):837-8. PubMed ID: 3546143
[TBL] [Abstract][Full Text] [Related]
10. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.
Arad G; Levy R; Hillman D; Kaempfer R
Nat Med; 2000 Apr; 6(4):414-21. PubMed ID: 10742148
[TBL] [Abstract][Full Text] [Related]
11. Molecular structure of staphylococcus and streptococcus superantigens.
Schlievert PM; Bohach GA; Ohlendorf DH; Stauffacher CV; Leung DY; Murray DL; Prasad GS; Earhart CA; Jablonski LM; Hoffmann ML; Chi YI
J Clin Immunol; 1995 Nov; 15(6 Suppl):4S-10S. PubMed ID: 8613491
[TBL] [Abstract][Full Text] [Related]
12. Cellular and molecular mechanisms of immune activation by microbial superantigens: studies using toxic shock syndrome toxin-1.
Chatila T; Scholl P; Ramesh N; Trede N; Fuleihan R; Morio T; Geha RS
Chem Immunol; 1992; 55():146-71. PubMed ID: 1418616
[No Abstract] [Full Text] [Related]
13. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses.
Bohach GA; Fast DJ; Nelson RD; Schlievert PM
Crit Rev Microbiol; 1990; 17(4):251-72. PubMed ID: 2206394
[TBL] [Abstract][Full Text] [Related]
14. Development of serum IgM antibodies against superantigens of Staphylococcus aureus and Streptococcus pyogenes in Kawasaki disease.
Matsubara K; Fukaya T; Miwa K; Shibayama N; Nigami H; Harigaya H; Nozaki H; Hirata T; Baba K; Suzuki T; Ishiguro A
Clin Exp Immunol; 2006 Mar; 143(3):427-34. PubMed ID: 16487241
[TBL] [Abstract][Full Text] [Related]
15. Staphylococcal and streptococcal superantigens: molecular, biological and clinical aspects.
Alouf JE; Müller-Alouf H
Int J Med Microbiol; 2003 Feb; 292(7-8):429-40. PubMed ID: 12635926
[TBL] [Abstract][Full Text] [Related]
16. Superantigens SPEA and SMEZ do not affect secretome expression in Streptococcus pyogenes.
Russell HH; Sriskandan S
Microb Pathog; 2008 Jun; 44(6):537-43. PubMed ID: 18329243
[TBL] [Abstract][Full Text] [Related]
17. Superantigens and streptococcal toxic shock syndrome.
Proft T; Sriskandan S; Yang L; Fraser JD
Emerg Infect Dis; 2003 Oct; 9(10):1211-8. PubMed ID: 14609454
[TBL] [Abstract][Full Text] [Related]
18. Characterization and distribution of a new enterotoxin-related superantigen produced by Staphylococcus aureus.
Abe J; Ito Y; Onimaru M; Kohsaka T; Takeda T
Microbiol Immunol; 2000; 44(2):79-88. PubMed ID: 10803494
[TBL] [Abstract][Full Text] [Related]
19. Dual infections with Staphylococcus aureus and Streptococcus pyogenes causing toxic shock syndrome. Possible synergistic effects of toxic shock syndrome toxin 1 and streptococcal pyrogenic exotoxin C.
Smith RJ; Schlievert PM; Himelright IM; Baddour LM
Diagn Microbiol Infect Dis; 1994 Aug; 19(4):245-7. PubMed ID: 7851088
[TBL] [Abstract][Full Text] [Related]
20. Staphylococcus aureus toxic shock syndrome toxin 1 and Streptococcus pyogenes erythrogenic toxin A modulate inflammatory mediator release from human neutrophils.
Hensler T; Köller M; Geoffroy C; Alouf JE; König W
Infect Immun; 1993 Mar; 61(3):1055-61. PubMed ID: 8381770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
